Mesoblast Limited
MESO
$16.11
$0.090.56%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 458.55% | 458.55% | -6.85% | -6.85% | -41.23% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 458.55% | 458.55% | -6.85% | -6.85% | -41.23% |
| Cost of Revenue | 45.91% | 45.91% | -183.56% | -183.56% | 3.33% |
| Gross Profit | -10.57% | -10.57% | 317.74% | 317.74% | -10.50% |
| SG&A Expenses | 63.88% | 63.88% | 49.70% | 49.70% | 18.70% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 334.57% | 334.57% | 104.76% | 104.76% | -63.51% |
| Total Operating Expenses | 66.66% | 66.66% | -22.79% | -22.79% | -20.11% |
| Operating Income | -35.27% | -35.27% | 24.83% | 24.83% | 17.74% |
| Income Before Tax | 2.55% | 2.55% | -46.20% | -46.20% | -26.39% |
| Income Tax Expenses | 232.58% | 232.58% | 307.84% | 307.84% | -11.25% |
| Earnings from Continuing Operations | 2.18% | 2.18% | -47.31% | -47.31% | -26.41% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 2.18% | 2.18% | -47.31% | -47.31% | -26.41% |
| EBIT | -35.27% | -35.27% | 24.83% | 24.83% | 17.74% |
| EBITDA | -28.70% | -28.70% | 26.02% | 26.02% | 17.72% |
| EPS Basic | 15.48% | 15.48% | -12.90% | -12.90% | -8.15% |
| Normalized Basic EPS | 18.32% | 18.32% | -3.48% | -3.48% | 16.03% |
| EPS Diluted | 15.48% | 15.48% | -12.90% | -12.90% | -8.15% |
| Normalized Diluted EPS | 18.32% | 18.32% | -3.48% | -3.48% | 16.03% |
| Average Basic Shares Outstanding | 15.96% | 15.96% | 30.49% | 30.49% | 16.57% |
| Average Diluted Shares Outstanding | 15.96% | 15.96% | 30.49% | 30.49% | 16.57% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |